熱門資訊> 正文

CompASS Pathways ADS GAAP每股收益为-1.88美元

2026-08-05 18:38

COMPASS Pathways(CMPS) 0

COMPASS Pathways ADS press release (CMPS): 1H GAAP EPS of -$1.88.
Cash and cash equivalents were $433.3 million as of June 30, 2026, compared with $149.6 million as of December 31, 2025.
Debt was $50.7 million as of June 30, 2026, compared with $31.6 million as of December 31, 2025.
Financial Guidance
The current cash position is expected to be sufficient to fund operating expenses and capital expenditure requirements into 2028.

More on COMPASS Pathways ADS

Compass Pathways: The Psilocybin Biotech Leader With Strong Momentum
Compass Pathways: 'Strong Buy' COMP360 Trial Wins And Q4 NDA Full Submission
Compass Pathways Phase 3 COMP006 Data Review
Psilocybin shown to ease PTSD in veterans in small study
Psychedelic drugmakers could get boost from HHS, VA memorandum

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。